Rua Releases Market Insights

Rua Bioscience (NZX: RUA) has released its Market Insights for 2023. The update is designed to share information about the challenges and opportunities presented by emerging high-value medicinal cannabis markets. CEO, Paul Naske, says "as we progress conversations and negotiations in Europe, our understanding of global medicinal cannabis markets evolves. This update provides an opportunity for Rua to share some of our most recent findings, focusing on Europe, Australia and New Zealand." The update is released as the company prepares for the launch of its first medicine in Germany. The person(s) who authorised this announcement: Paul Naske, Chief Executive Officer For shareholder enquiries please visit www.ruabio.com, or contact: Kerry Donovan Communications and Corporate Affairs Manager info@ruabio.com 0800 RUABIO End CA:00408686 For:RUA Type:GENERAL Time:2023-03-21 11:34:14